Sienna Biopharmaceuticals, Inc. (SNNAQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Sienna Biopharmaceuticals Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 20.39M |
| June 30, 2019 | 80.64M |
| March 31, 2019 | 81.77M |
| December 31, 2018 | 80.72M |
| September 30, 2018 | 79.70M |
| June 30, 2018 | 80.19M |
| Date | Value |
|---|---|
| March 31, 2018 | 47.12M |
| December 31, 2017 | 45.65M |
| September 30, 2017 | 53.05M |
| June 30, 2017 | 48.00M |
| March 31, 2017 | 47.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 859.67M |
| Corcept Therapeutics, Inc. | 176.89M |
| Assertio Holdings, Inc. | 135.67M |
| Veru, Inc. | 8.297M |
| Johnson & Johnson | 119.71B |